Neumora Therapeutics, Inc. (NMRA)
1.50
-0.02
(-1.64%)
USD |
NASDAQ |
Aug 25, 16:00
1.50
0.00 (0.00%)
After-Hours: 19:59
Neumora Therapeutics Market Cap : 280.28M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 25, 2026 | 280.28M |
| August 24, 2026 | 284.95M |
| August 21, 2026 | 304.57M |
| August 20, 2026 | 283.08M |
| August 19, 2026 | 306.44M |
| August 18, 2026 | 306.44M |
| August 17, 2026 | 284.01M |
| August 14, 2026 | 298.96M |
| August 13, 2026 | 323.25M |
| August 12, 2026 | 319.52M |
| August 11, 2026 | 317.65M |
| August 10, 2026 | 295.09M |
| August 07, 2026 | 296.92M |
| August 06, 2026 | 298.74M |
| August 05, 2026 | 293.27M |
| August 04, 2026 | 291.45M |
| August 03, 2026 | 298.74M |
| July 31, 2026 | 293.27M |
| July 30, 2026 | 300.56M |
| July 29, 2026 | 300.56M |
| July 28, 2026 | 306.02M |
| July 27, 2026 | 302.38M |
| July 24, 2026 | 271.41M |
| July 23, 2026 | 284.16M |
| July 22, 2026 | 280.52M |
| Date | Value |
|---|---|
| July 21, 2026 | 294.18M |
| July 20, 2026 | 296.92M |
| July 17, 2026 | 293.27M |
| July 16, 2026 | 291.45M |
| July 15, 2026 | 296.92M |
| July 14, 2026 | 287.81M |
| July 13, 2026 | 291.45M |
| July 10, 2026 | 306.02M |
| July 09, 2026 | 300.56M |
| July 08, 2026 | 289.63M |
| July 07, 2026 | 315.13M |
| July 06, 2026 | 307.85M |
| July 02, 2026 | 304.20M |
| July 01, 2026 | 295.09M |
| June 30, 2026 | 309.67M |
| June 29, 2026 | 313.31M |
| June 26, 2026 | 298.74M |
| June 25, 2026 | 275.06M |
| June 24, 2026 | 265.95M |
| June 23, 2026 | 293.27M |
| June 22, 2026 | 278.70M |
| June 18, 2026 | 275.06M |
| June 17, 2026 | 278.70M |
| June 16, 2026 | 284.16M |
| June 15, 2026 | 166.58M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 657.78B |
| Indivior Pharmaceuticals, Inc. | 4.244B |
| Liquidia Corp. | 6.281B |
| BioAge Labs, Inc. | 462.80M |
| LB Pharmaceuticals, Inc. | 1.400B |
Market Cap Related Metrics
| Price to Book Value | 6.296 |
| Price | 1.50 |
| Earnings Yield | -82.23% |